Skip to main content
Log in

Literature review, case report, and expert discussion of prolonged refractory status epilepticus

  • Cases With Tough Decisions
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

We report the case of a 30-year-old woman with severe, prolonged refractory status epilepticus requiring more than 6 months of iatrogenic coma. Opinions on prognosis and clinical management were solicited from a number of experienced neurointensivists and epileptologists at multiple time-points during the clinical course. The ensuing discussion, annotated with references, is presented here. Several experts commented on isolated cases of young patients with encephalitis requiring up to 2–3 months of iatrogenic coma, yet still having good outcomes. Treatments discussed include ketamine, gammaglobulin, plasmapheresis, steroids, adrenocorticotropic hormone, very high-dose phenobarbital, isoflurane, lidocaine, electroconvulsive therapy, ketogenic diet, hypothermia, magnesium, transcranial magnetic stimulation, vagus nerve stimulation, deep brain stimulation, and neurosurgery. The patient eventually suffered a cardiac arrest but was resuscitated as requested by the family. Seizures then stopped, and the patient has remained in a persistent vegetative state since.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. DeBiasi RL, Kleinschmidt-DeMasters BK, Weinberg A, Tyler KL. Use of PCR for the diagnosis of herpesvirus infections of the central nervous system. J Clin Virol 2002;25(Suppl 1):S5-S11.

    Article  PubMed  CAS  Google Scholar 

  2. Hirsch LJ, Claassen J, Mayer SA, Emerson RG. Stimulus-induced rhythmic, periodic, or ictal discharges (SIRPIDs): a common EEG phenomenon in the critically ill. Epilepsia 2004;45(2):109–123.

    Article  PubMed  Google Scholar 

  3. Chaudhuri A, Kennedy PG. Diagnosis and treatment of viral encephalitis. Postgrad Med J 2002;78(924):575–583.

    Article  PubMed  CAS  Google Scholar 

  4. Johnson RT. Viral Infections of the Nervous System. Philadelphia: Lippincott-Raven; 1998.

    Google Scholar 

  5. Booss J, Esiri MM. Viral Encephalitis: Pathology, Diagnosis and Management. Blackwell Scientific, Oxford, UK, 1986.

    Google Scholar 

  6. Booss J, Esiri MM. Viral Encephalitis in Humans. ASM, Washington, DC, 2003.

    Google Scholar 

  7. Einsiedel L, Kat E, Ravindran J, Slavotinek J, Gordon DL. MR findings in Murray Valley encephalitis. AJNR Am J Neuroradiol 2003;24(7):1379–1382.

    PubMed  Google Scholar 

  8. Kalita J, Misra UK. Comparison of CT and MRI findings in the diagnosis of Japanese encephalitis. J Neurol Sci 2000; 174:3–8.

    Article  PubMed  CAS  Google Scholar 

  9. Kennedy PG. Viral encephalitis: causes, differential diagnosis, and management. J Neurol Neurosurg Psychiatry 2004;75 (Suppl 1):i10-i15.

    Article  PubMed  Google Scholar 

  10. Treiman DM, Meyers PD, Walton NY. A comparison of four treatments for generalized convulsive status epilepticus: Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998;17:792–798.

    Article  Google Scholar 

  11. DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent non-convulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998;39(8):833–840.

    Article  PubMed  CAS  Google Scholar 

  12. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital propofol, or midazolam: a systematic review. Epilepsia 2002;43(2):146–153.

    Article  PubMed  CAS  Google Scholar 

  13. Sinha S, Naritoku DK. Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology 2000;55(5): 722–724.

    PubMed  CAS  Google Scholar 

  14. Mirski MA, Williams MA, Hanley DF. Prolonged pentobarbital and phenobarbital coma for refractory generalized status epilepticus. Crit Care Med 1995;23(2):400–404.

    Article  PubMed  CAS  Google Scholar 

  15. Crawford TO, Mitchell WG, Fishman LS, Snodgrass SR. Very-high-dose phenobarbital for refractory status epilepticus in children. Neurology 1988;38(7):1035–1040.

    PubMed  CAS  Google Scholar 

  16. Krishnamurthy KB, Drislane FW. Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia 1999;40(6):759–762.

    Article  PubMed  CAS  Google Scholar 

  17. Krishnamurthy KB, Drislane FW. Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia 1996;37(9):863–867.

    Article  PubMed  CAS  Google Scholar 

  18. Sahin M, Menache CC, Holmes GL, Riviello JJ, Jr. Prolonged treatment for acute symptomatic refractory status epilepticus: outcome in children. Neurology 2003;61(3):398–401.

    PubMed  Google Scholar 

  19. Chinnery PF, Turnbull DM. Clinical features, investigation, and management of patients with defects of mitochondrial DNA. J Neurol Neurosurg Psychiatry 1997;63:559–563.

    PubMed  CAS  Google Scholar 

  20. Lamps LW, Scott MA. Cat-scratch disease: historic, clinical, and pathologic perspectives. Am J Clin Pathol 2004;121(Suppl):S71-S80.

    PubMed  Google Scholar 

  21. Singhal AB, Newstein MC, Budzik R, et al. Diffusion-weighted magnetic resonance imaging abnormalities in Bartonella encephalopathy. J Neuroimaging 2003;13(1):79–82.

    Article  PubMed  Google Scholar 

  22. Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol 2004;61(8):1254–1259.

    Article  PubMed  Google Scholar 

  23. Kofke WA, Young RS, Davis P, et al. Isoflurane for refractory status epilepticus: a clinical series. Anesthesiology 1989;71(5):653–659.

    Article  PubMed  CAS  Google Scholar 

  24. Jensen NF, Fiddler DS, Striepe V. Anesthetic considerations in porphyrias. Anesth Analg 1995;80(3):591–599.

    Article  PubMed  CAS  Google Scholar 

  25. Borris DJ, Bertram EH, Kapur J. Ketamine controls prolonged status epilepticus. Epilepsy Res 2000;42:117–122.

    Article  PubMed  CAS  Google Scholar 

  26. Bleck TP. Refractory status epilepticus in 2001. Arch Neurol 2002;59(2):188–189.

    Article  PubMed  Google Scholar 

  27. Williams AJ, Tortella FC, Lu XM, Moreton JE, Hartings JA. Antiepileptic drug treatment of nonconvulsive seizures induced by experimental focal brain ischemia. J Pharmacol Exp Ther 2004; 311(1):220–227.

    Article  PubMed  CAS  Google Scholar 

  28. Clifford DB, Olney JW, Benz AM, Fuller TA, Zorumski CF. Ketamine, phencyclidine, and MK-801 protect against kainic acid-induced seizure-related brain damage. Epilepsia 1990;31:382–390.

    Article  PubMed  CAS  Google Scholar 

  29. Sheth RD, Gidal BE, Refractory status epilepticus: response to ketamine. Neurology 1998;51(6):1765–1766.

    PubMed  CAS  Google Scholar 

  30. Mewasingh LD, Sekhara T, Aeby A, Christiaens FJ, Dan B. Oral ketamine in paediatric non-convulsive status epilepticus. Seizure 2003;12(7):483–489.

    Article  PubMed  CAS  Google Scholar 

  31. Brunson KL, Avishai-Elinder S, Baram TZ. ACTH treatment of infantile spasms: Mechanisms of its effects in modulation of neuronal excitability. Int Rev Neurobiol 2002;49:185–197.

    Article  PubMed  CAS  Google Scholar 

  32. Thieben M, Lennon V, Boeve B, Aksamit A, Keegan M, Vernino S. Potentially reversible autoimmune limbic encephalitis with potassium channel antibody. Neurology 2004;62(7):1177–1182.

    PubMed  CAS  Google Scholar 

  33. Vincent A, Buckley C, Schott J, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127(Pt3):701–712.

    PubMed  Google Scholar 

  34. Newsom-Davis J, Buckley C, Clover L, Hart I, Maddison P, Tuzum E, Vincent A. Autoimmune disorders of neuronal potassium channels. Ann NY Acad Sci 2003;998:202–210.

    Article  PubMed  CAS  Google Scholar 

  35. Villani F, Avanzini G. The use of immunoglobulins in the treatment of human epilepsy. Neurol Sci 2002;23(Suppl 1):S33-S37.

    Article  PubMed  Google Scholar 

  36. Emmi L, Chiarini F. The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders. Neurol Sci 2002;23(Suppl 1):S1-S8. Review.

    Article  PubMed  Google Scholar 

  37. Vastola EF, Homan R, Rosen A. Inhibition of focal seizures by moderate hypothermia. A clinical and experimental study. Arch Neurol 1969;20(4):430–439.

    PubMed  CAS  Google Scholar 

  38. Bassin S, Smith TL, Bleck TP. Clinical review: status epilepticus. Crit Care 2002;6(2):137–142.

    Article  PubMed  Google Scholar 

  39. Beeson D. Autoantibodies in the CNS: Encephalopathy and potassium channelopathy. Neurology 2004;52:1040–1041.

    Google Scholar 

  40. Claassen J, Hirsch LJ, Emerson RG, Bates JE, Thompson TB, Mayer SA. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology 2001; 57(6):1036–1042.

    PubMed  CAS  Google Scholar 

  41. Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002;59(2):205–210.

    Article  PubMed  Google Scholar 

  42. Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 2005;105(2):402–410.

    PubMed  Google Scholar 

  43. Iannetti P, Spalice A, Parisi P. Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus. Epilepsia 2005;46(6):967–969.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. J. Hirsch.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robakis, T.K., Hirsch, L.J. Literature review, case report, and expert discussion of prolonged refractory status epilepticus. Neurocrit Care 4, 35–46 (2006). https://doi.org/10.1385/NCC:4:1:035

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/NCC:4:1:035

Key Words

Navigation